Lekhim

Lekhim is a prominent Ukrainian pharmaceutical group established in 1992, operating as a full-cycle enterprise encompassing R&D, manufacturing, and distribution. The group consists of several major production sites, including Lekhim-Kharkiv and Lekhim-Obukhiv, which produce over 200 types of generic medicines across various therapeutic areas such as cardiology, neurology, and infectious diseases. Lekhim is recognized for its significant manufacturing capacity in diverse dosage forms, including being a leading producer of suppositories and injectable solutions in the region. The company gained international attention through its strategic partnership with Sinovac Biotech for the supply and localized fill-finish production of the CoronaVac COVID-19 vaccine in Ukraine. Lekhim maintains a strong market presence domestically and exports its pharmaceutical products to more than 30 countries worldwide.